Oral transmission of Candida albicans between partners in HIV-infected couples could contribute to dissemination of fluconazole-resistant isolates

AIDS

Volumn 11, Issue 9, 1997, Pages 1095-1101

  Dromer, Françoise ^a   Improvisi, Luce ^a   Dupont, Bertrand ^a   Eliaszewicz, Muriel ^a   Pialoux, Gilles ^a   Fournier, Sandra ^a   Feuillie, Vincent ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

Antifungal drug resistance; Candida albicans; Epidemiology; Fluconazole; Oropharyngeal candidiasis; Sexual partners; Transmission

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE;

ADULT; AGED; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CLINICAL ARTICLE; DISEASE TRANSMISSION; DRUG RESISTANCE; FEMALE; FUNGAL GENETICS; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TREATMENT FAILURE;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS, ORAL; DNA, FUNGAL; DRUG RESISTANCE, MICROBIAL; FEMALE; FLUCONAZOLE; HOMOSEXUALITY, MALE; HUMANS; MALE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SEXUAL PARTNERS; SEXUALITY; TIME FACTORS; VARIATION (GENETICS);

EID: 0030967369     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199709000-00003     Document Type: Article

References (28)

1. Cameron ML, Schell WA, Bruch S, Bartlett JA, Waskin HA, Perfect JR: Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type I. Antimicrob Agents Chemother 1993, 37:2449-2453.
2. Chavanet P, Lopez J, Grappin M, et al.: Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients. AIDS 1994, 8:945-950.
3. Coleman DC, Bennett DE, Sullivan DJ, et al.: Oral Candida in HIV infection and AIDS: new perspectives/new approaches. Crit Rev Microbiol 1993, 19:61-82.
4. Garcia-Hermoso D, Dromer F, Improvisi L, Provost F, Dupont B: Fluconazole concentrations in saliva from AIDS patients with oropharyngeal candidosis refractory to treatment with FCZ. Antimicrob Agents Chemother 1995, 39:656-660.
5. Newman SL, Flanigan TP, Fisher A, Rinaldi MG, Stein M, Vigilante K: Clinically significant mucosal candidiasis resistant to fluconazole in patients with AIDS. Clin Infect Dis 1994, 19:684-686.
6. Ruhnke M, Eigler A, Geiseler B, Engelmann E, Trautmann M: Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. J Clin Microbiol 1994, 32:2092-2098.
7. Baily GG, Perry FM, Denning DW, Mandal BK: Fluconazole-resistant candidosis in an HIV cohort. AIDS 1994, 8:787-792.
8. Heinic GS, Stevens DA, Greenspan D, et al.: Fluconazole-resistant Candida in AIDS patients. Oral Surg Oral Med Oral Pathol 1993, 76:711-715.
9. White A, Goetz MB: Azole-resistant Candida albicans: report of two cases of resistance to fluconazole and review. Clin Infect Dis 1994, 19:687-692.
10. Bart-Delabesse E, Boiron P, Carlotti A, Dupont B: Candida albicans genotyping in studies with patients with AIDS developing resistance to fluconazole. J Clin Microbiol 1993, 31:2933-2937.
11. Millon L, Manteaux A, Reboux G, et al.: Fluconazole-resistant recurrent candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype. J Clin Microbiol 1994, 32:1115-1118.
12. Redding S, Smith J, Farinacci G, et al.: Resistance of Candida albicans to fluconazole during treatment of oropahryngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. Clin Infect Dis 1994, 18:240-242.
13. Barchiesi F, Hollis RJ, McGough DA, Scalise G, Rinaldi MG, Pfaller MA: DNA subtypes and fluconazole susceptibilities of Candida albicans isolates from the oral cavities of patients with AIDS. Clin Infect Dis 1995, 20:634-640.
14. Boerlin P, Addo M, Durussel C, Pagani JL, Chave JP, Bille J: Transmission of oral Candida albicans strains between HIV-positive patients [letter]. Lancet 1995, 343:1052-1053.
15. Dellion S, Improvisi L, Dupont B, Dromer F: Diversity among yeasts isolated from patients with AIDS and oral candidosis, especially regarding fluconazole susceptibility. J Mycol Méd 1995, 5:98-101.
16. Goff DA, Koletar SL, Buesching WJ, Barnishan J, Fass RJ: Isolation of fluconazole-resistant Candida albicans from human immunodeficiency virus-negative patients never treated with azoles. Clin Infect Dis 1995, 20:77-83.
17. Bart-Delabesse E, van Deventer H, Goessens W, et al.: Contribution of molecular typing methods and antifungal susceptibility testing to the study of a candidemia cluster in a burn care unit. J Clin Microbiol 1995, 33:3278-3283.
18. National Committee for Clinical Laboratory Standards: Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Proposed Standard. [Document M27-P.] Villanova: National Committee for Clinical Laboratory Standards: 1992.
19. Voss A, Pfaller MA, Hollis RJ, Rhine-Chalberg J, Doebbeling BN: Investigation of Candida albicans transmission in a surgical intensive care unit cluster by using genomic DNA typing methods. J Clin Microbiol 1995, 33:575-580.
20. Romano F, Ribera G, Giuliano M: A study of a hospital cluster of systemic candidosis using DNA typing methods. Epidemiol Infect 1994, 112:393-398.
21. Schmid J, Rotman M, Reed B, Pierson CL, Soll DR: Genetic similarity of Candida albicans strains from vaginitis patients and their partner. J Clin Microbiol 1993, 31:39-46.
22. Sangeorzan JA, Bradley SF, He X, et al.: Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Am J Med 1994, 97:339-346.
23. Pfaller MA, Rhine-Chalberg J, Redding SW, et al.: Variations in fluconazole susceptibility and eletrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis. J Clin Microbiol 1994, 32:59-64.
24. Schmid J, Odds FC, Wiselka MJ, Nicholson KG, Soll DR: Genetic similarity and maintenance of Candida albicans strains from a group of AIDS patients, demonstrated by DNA finger-printing. J Clin Microbiol 1992, 30:935-941.
25. McCullough M, Ross B, Reade P: Characterization of genetically distinct subgroup of Candida albicans strains isolated from oral cavities of patients infected with human immunodeficiency virus. J Clin Microbiol 1995, 33:695-700.
26. Hellstein J, Vawter-Hugart M, Fotos P, Schmid J, Soll DR: Genetic similarity and phenotypic diversity of commensal and pathogenic strains of Candida albicans isolated from the oral cavity. J Clin Microbiol 1991, 31:3190-3199.
27. Dupont B, Improvisi L, Eliaszewicz M, Pialoux G, GEMO: Resistance of Candida albicans to fluconazole (FCZ) in AIDS patients. 32nd International Conference on Antimicrobial Agents and Chemotherapy, Anaheim, October 1992 [abstract 1203].
28. Velez JD, Allendoerfer R, Luther M, Rinaldi MG, Gravbill JR: Correlation of in vitro azole susceptibility with in vivo response in a murine model of cryptococcal meningitis. J Infect Dis 1993, 168:508-510.